CN110408647A - A kind of construction method of biology mutant library - Google Patents
A kind of construction method of biology mutant library Download PDFInfo
- Publication number
- CN110408647A CN110408647A CN201910274109.7A CN201910274109A CN110408647A CN 110408647 A CN110408647 A CN 110408647A CN 201910274109 A CN201910274109 A CN 201910274109A CN 110408647 A CN110408647 A CN 110408647A
- Authority
- CN
- China
- Prior art keywords
- dna
- genetically modified
- mutant library
- target
- modified organism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010276 construction Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 48
- 238000013467 fragmentation Methods 0.000 claims abstract description 45
- 238000006062 fragmentation reaction Methods 0.000 claims abstract description 45
- 235000003869 genetically modified organism Nutrition 0.000 claims abstract description 26
- 238000002703 mutagenesis Methods 0.000 claims abstract description 13
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 13
- 230000002411 adverse Effects 0.000 claims abstract description 11
- 229930000044 secondary metabolite Natural products 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 107
- 230000014509 gene expression Effects 0.000 claims description 43
- 230000007023 DNA restriction-modification system Effects 0.000 claims description 21
- 108091008146 restriction endonucleases Proteins 0.000 claims description 21
- 230000033458 reproduction Effects 0.000 claims description 17
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 14
- 238000012216 screening Methods 0.000 claims description 8
- 230000009261 transgenic effect Effects 0.000 claims description 8
- 238000010443 CRISPR/Cpf1 gene editing Methods 0.000 claims description 5
- 238000010453 CRISPR/Cas method Methods 0.000 claims description 4
- 230000009946 DNA mutation Effects 0.000 claims description 4
- 108091028113 Trans-activating crRNA Proteins 0.000 claims description 4
- 230000004790 biotic stress Effects 0.000 claims description 4
- 230000021121 meiosis Effects 0.000 claims description 3
- 238000013465 asexual reproduction Methods 0.000 claims 1
- 230000011681 asexual reproduction Effects 0.000 claims 1
- 238000013464 organism reproduction Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 36
- 108090000623 proteins and genes Proteins 0.000 description 36
- 241000196324 Embryophyta Species 0.000 description 35
- 241000219194 Arabidopsis Species 0.000 description 12
- 230000035772 mutation Effects 0.000 description 12
- 108091033409 CRISPR Proteins 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- 230000004720 fertilization Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 229930182566 Gentamicin Natural products 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 101100020617 Solanum lycopersicum LAT52 gene Proteins 0.000 description 3
- 230000036579 abiotic stress Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010362 genome editing Methods 0.000 description 3
- 229960002518 gentamicin Drugs 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 2
- FRBAHXABMQXSJQ-FXQIFTODSA-N Arg-Ser-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FRBAHXABMQXSJQ-FXQIFTODSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 2
- QPXBPQUGXHURGP-UWVGGRQHSA-N Leu-Gly-Met Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N QPXBPQUGXHURGP-UWVGGRQHSA-N 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010054155 lysyllysine Proteins 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000024053 secondary metabolic process Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 1
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 1
- JPGBXANAQYHTLA-DRZSPHRISA-N Ala-Gln-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JPGBXANAQYHTLA-DRZSPHRISA-N 0.000 description 1
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- KYDYGANDJHFBCW-DRZSPHRISA-N Ala-Phe-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KYDYGANDJHFBCW-DRZSPHRISA-N 0.000 description 1
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- JUWQNWXEGDYCIE-YUMQZZPRSA-N Arg-Gln-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O JUWQNWXEGDYCIE-YUMQZZPRSA-N 0.000 description 1
- RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- JBIRFLWXWDSDTR-CYDGBPFRSA-N Arg-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCN=C(N)N)N JBIRFLWXWDSDTR-CYDGBPFRSA-N 0.000 description 1
- LCBSSOCDWUTQQV-SDDRHHMPSA-N Arg-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LCBSSOCDWUTQQV-SDDRHHMPSA-N 0.000 description 1
- CZUHPNLXLWMYMG-UBHSHLNASA-N Arg-Phe-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 CZUHPNLXLWMYMG-UBHSHLNASA-N 0.000 description 1
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 1
- UIUXXFIKWQVMEX-UFYCRDLUSA-N Arg-Phe-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UIUXXFIKWQVMEX-UFYCRDLUSA-N 0.000 description 1
- 108010051330 Arg-Pro-Gly-Pro Proteins 0.000 description 1
- SJPZTWAYTJPPBI-GUBZILKMSA-N Asn-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SJPZTWAYTJPPBI-GUBZILKMSA-N 0.000 description 1
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 1
- AYOAHKWVQLNPDM-HJGDQZAQSA-N Asn-Lys-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AYOAHKWVQLNPDM-HJGDQZAQSA-N 0.000 description 1
- FHCRKXCTKSHNOE-QEJZJMRPSA-N Asn-Trp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FHCRKXCTKSHNOE-QEJZJMRPSA-N 0.000 description 1
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 1
- LTDGPJKGJDIBQD-LAEOZQHASA-N Asn-Val-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LTDGPJKGJDIBQD-LAEOZQHASA-N 0.000 description 1
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 1
- XOQYDFCQPWAMSA-KKHAAJSZSA-N Asn-Val-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOQYDFCQPWAMSA-KKHAAJSZSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- JGDBHIVECJGXJA-FXQIFTODSA-N Asp-Asp-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JGDBHIVECJGXJA-FXQIFTODSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- KIHRUISMQZVCNO-ZLUOBGJFSA-N Cys-Asp-Asp Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KIHRUISMQZVCNO-ZLUOBGJFSA-N 0.000 description 1
- LYSHSHHDBVKJRN-JBDRJPRFSA-N Cys-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CS)N LYSHSHHDBVKJRN-JBDRJPRFSA-N 0.000 description 1
- UBHPUQAWSSNQLQ-DCAQKATOSA-N Cys-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CS)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O UBHPUQAWSSNQLQ-DCAQKATOSA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- IGNGBUVODQLMRJ-CIUDSAMLSA-N Gln-Ala-Met Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IGNGBUVODQLMRJ-CIUDSAMLSA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- CGVWDTRDPLOMHZ-FXQIFTODSA-N Gln-Glu-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CGVWDTRDPLOMHZ-FXQIFTODSA-N 0.000 description 1
- LLRJEFPKIIBGJP-DCAQKATOSA-N Gln-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N LLRJEFPKIIBGJP-DCAQKATOSA-N 0.000 description 1
- JEFZIKRIDLHOIF-BYPYZUCNSA-N Gln-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(O)=O JEFZIKRIDLHOIF-BYPYZUCNSA-N 0.000 description 1
- PODFFOWWLUPNMN-DCAQKATOSA-N Gln-His-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PODFFOWWLUPNMN-DCAQKATOSA-N 0.000 description 1
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 1
- IIMZHVKZBGSEKZ-SZMVWBNQSA-N Gln-Trp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O IIMZHVKZBGSEKZ-SZMVWBNQSA-N 0.000 description 1
- WTJIWXMJESRHMM-XDTLVQLUSA-N Gln-Tyr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O WTJIWXMJESRHMM-XDTLVQLUSA-N 0.000 description 1
- ATRHMOJQJWPVBQ-DRZSPHRISA-N Glu-Ala-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ATRHMOJQJWPVBQ-DRZSPHRISA-N 0.000 description 1
- FLLRAEJOLZPSMN-CIUDSAMLSA-N Glu-Asn-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FLLRAEJOLZPSMN-CIUDSAMLSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- WVTIBGWZUMJBFY-GUBZILKMSA-N Glu-His-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O WVTIBGWZUMJBFY-GUBZILKMSA-N 0.000 description 1
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 1
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 1
- OCQUNKSFDYDXBG-QXEWZRGKSA-N Gly-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OCQUNKSFDYDXBG-QXEWZRGKSA-N 0.000 description 1
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 1
- 108010050006 Gly-Asp-Gly-Arg Proteins 0.000 description 1
- LXXLEUBUOMCAMR-NKWVEPMBSA-N Gly-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)CN)C(=O)O LXXLEUBUOMCAMR-NKWVEPMBSA-N 0.000 description 1
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 1
- CCQOOWAONKGYKQ-BYPYZUCNSA-N Gly-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)CN CCQOOWAONKGYKQ-BYPYZUCNSA-N 0.000 description 1
- IDOGEHIWMJMAHT-BYPYZUCNSA-N Gly-Gly-Cys Chemical compound NCC(=O)NCC(=O)N[C@@H](CS)C(O)=O IDOGEHIWMJMAHT-BYPYZUCNSA-N 0.000 description 1
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 1
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 1
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 1
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 1
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 1
- UIQGJYUEQDOODF-KWQFWETISA-N Gly-Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 UIQGJYUEQDOODF-KWQFWETISA-N 0.000 description 1
- RYAOJUMWLWUGNW-QMMMGPOBSA-N Gly-Val-Gly Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O RYAOJUMWLWUGNW-QMMMGPOBSA-N 0.000 description 1
- BNMRSWQOHIQTFL-JSGCOSHPSA-N Gly-Val-Phe Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 BNMRSWQOHIQTFL-JSGCOSHPSA-N 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- VOKCBYNCZVSILJ-KKUMJFAQSA-N His-Asn-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CN=CN2)N)O VOKCBYNCZVSILJ-KKUMJFAQSA-N 0.000 description 1
- AZEYWPUCOYXFOE-CYDGBPFRSA-N Ile-Arg-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N AZEYWPUCOYXFOE-CYDGBPFRSA-N 0.000 description 1
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 1
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
- JRYQSFOFUFXPTB-RWRJDSDZSA-N Ile-Gln-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N JRYQSFOFUFXPTB-RWRJDSDZSA-N 0.000 description 1
- PDTMWFVVNZYWTR-NHCYSSNCSA-N Ile-Gly-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O PDTMWFVVNZYWTR-NHCYSSNCSA-N 0.000 description 1
- HYLIOBDWPQNLKI-HVTMNAMFSA-N Ile-His-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N HYLIOBDWPQNLKI-HVTMNAMFSA-N 0.000 description 1
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 1
- UDBPXJNOEWDBDF-XUXIUFHCSA-N Ile-Lys-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O)N UDBPXJNOEWDBDF-XUXIUFHCSA-N 0.000 description 1
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 1
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 1
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 1
- IPFKIGNDTUOFAF-CYDGBPFRSA-N Ile-Val-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IPFKIGNDTUOFAF-CYDGBPFRSA-N 0.000 description 1
- JCGMFFQQHJQASB-PYJNHQTQSA-N Ile-Val-His Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O JCGMFFQQHJQASB-PYJNHQTQSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 1
- OGCQGUIWMSBHRZ-CIUDSAMLSA-N Leu-Asn-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OGCQGUIWMSBHRZ-CIUDSAMLSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 1
- MPSBSKHOWJQHBS-IHRRRGAJSA-N Leu-His-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N MPSBSKHOWJQHBS-IHRRRGAJSA-N 0.000 description 1
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 1
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 1
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- YUTNOGOMBNYPFH-XUXIUFHCSA-N Leu-Pro-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YUTNOGOMBNYPFH-XUXIUFHCSA-N 0.000 description 1
- XXXXOVFBXRERQL-ULQDDVLXSA-N Leu-Pro-Phe Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XXXXOVFBXRERQL-ULQDDVLXSA-N 0.000 description 1
- ICYRCNICGBJLGM-HJGDQZAQSA-N Leu-Thr-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- MPOHDJKRBLVGCT-CIUDSAMLSA-N Lys-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N MPOHDJKRBLVGCT-CIUDSAMLSA-N 0.000 description 1
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- AFLBTVGQCQLOFJ-AVGNSLFASA-N Lys-Pro-Arg Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-AVGNSLFASA-N 0.000 description 1
- UQJOKDAYFULYIX-AVGNSLFASA-N Lys-Pro-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 UQJOKDAYFULYIX-AVGNSLFASA-N 0.000 description 1
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 1
- WZVSHTFTCYOFPL-GARJFASQSA-N Lys-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N)C(=O)O WZVSHTFTCYOFPL-GARJFASQSA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 1
- YRAWWKUTNBILNT-FXQIFTODSA-N Met-Ala-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YRAWWKUTNBILNT-FXQIFTODSA-N 0.000 description 1
- MYAPQOBHGWJZOM-UWVGGRQHSA-N Met-Gly-Leu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C MYAPQOBHGWJZOM-UWVGGRQHSA-N 0.000 description 1
- LQMHZERGCQJKAH-STQMWFEESA-N Met-Gly-Phe Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 LQMHZERGCQJKAH-STQMWFEESA-N 0.000 description 1
- HZLSUXCMSIBCRV-RVMXOQNASA-N Met-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCSC)N HZLSUXCMSIBCRV-RVMXOQNASA-N 0.000 description 1
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 1
- TUZSWDCTCGTVDJ-PJODQICGSA-N Met-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 TUZSWDCTCGTVDJ-PJODQICGSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 1
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 1
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 1
- GHNVJQZQYKNTDX-HJWJTTGWSA-N Phe-Ile-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O GHNVJQZQYKNTDX-HJWJTTGWSA-N 0.000 description 1
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 1
- XZQYIJALMGEUJD-OEAJRASXSA-N Phe-Lys-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XZQYIJALMGEUJD-OEAJRASXSA-N 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- QBFONMUYNSNKIX-AVGNSLFASA-N Pro-Arg-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QBFONMUYNSNKIX-AVGNSLFASA-N 0.000 description 1
- MTHRMUXESFIAMS-DCAQKATOSA-N Pro-Asn-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O MTHRMUXESFIAMS-DCAQKATOSA-N 0.000 description 1
- KQCCDMFIALWGTL-GUBZILKMSA-N Pro-Asn-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 KQCCDMFIALWGTL-GUBZILKMSA-N 0.000 description 1
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- FEPSEIDIPBMIOS-QXEWZRGKSA-N Pro-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 FEPSEIDIPBMIOS-QXEWZRGKSA-N 0.000 description 1
- LPGSNRSLPHRNBW-AVGNSLFASA-N Pro-His-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 LPGSNRSLPHRNBW-AVGNSLFASA-N 0.000 description 1
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- AJJDPGVVNPUZCR-RHYQMDGZSA-N Pro-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1)O AJJDPGVVNPUZCR-RHYQMDGZSA-N 0.000 description 1
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 1
- XDKKMRPRRCOELJ-GUBZILKMSA-N Pro-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 XDKKMRPRRCOELJ-GUBZILKMSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- NLQUOHDCLSFABG-GUBZILKMSA-N Ser-Arg-Arg Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NLQUOHDCLSFABG-GUBZILKMSA-N 0.000 description 1
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- YIUWWXVTYLANCJ-NAKRPEOUSA-N Ser-Ile-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YIUWWXVTYLANCJ-NAKRPEOUSA-N 0.000 description 1
- KCNSGAMPBPYUAI-CIUDSAMLSA-N Ser-Leu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KCNSGAMPBPYUAI-CIUDSAMLSA-N 0.000 description 1
- NIOYDASGXWLHEZ-CIUDSAMLSA-N Ser-Met-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O NIOYDASGXWLHEZ-CIUDSAMLSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- FLONGDPORFIVQW-XGEHTFHBSA-N Ser-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FLONGDPORFIVQW-XGEHTFHBSA-N 0.000 description 1
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 1
- KIEIJCFVGZCUAS-MELADBBJSA-N Ser-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N)C(=O)O KIEIJCFVGZCUAS-MELADBBJSA-N 0.000 description 1
- SGZVZUCRAVSPKQ-FXQIFTODSA-N Ser-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N SGZVZUCRAVSPKQ-FXQIFTODSA-N 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- CEXFELBFVHLYDZ-XGEHTFHBSA-N Thr-Arg-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CEXFELBFVHLYDZ-XGEHTFHBSA-N 0.000 description 1
- SKHPKKYKDYULDH-HJGDQZAQSA-N Thr-Asn-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SKHPKKYKDYULDH-HJGDQZAQSA-N 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 1
- WNQJTLATMXYSEL-OEAJRASXSA-N Thr-Phe-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WNQJTLATMXYSEL-OEAJRASXSA-N 0.000 description 1
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 1
- VTMGKRABARCZAX-OSUNSFLBSA-N Thr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O VTMGKRABARCZAX-OSUNSFLBSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 1
- DVIIYMVCSUQOJG-QEJZJMRPSA-N Trp-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DVIIYMVCSUQOJG-QEJZJMRPSA-N 0.000 description 1
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 1
- DXYWRYQRKPIGGU-BPNCWPANSA-N Tyr-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DXYWRYQRKPIGGU-BPNCWPANSA-N 0.000 description 1
- OGPKMBOPMDTEDM-IHRRRGAJSA-N Tyr-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N OGPKMBOPMDTEDM-IHRRRGAJSA-N 0.000 description 1
- NWEGIYMHTZXVBP-JSGCOSHPSA-N Tyr-Val-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O NWEGIYMHTZXVBP-JSGCOSHPSA-N 0.000 description 1
- IVXJODPZRWHCCR-JYJNAYRXSA-N Val-Arg-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IVXJODPZRWHCCR-JYJNAYRXSA-N 0.000 description 1
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 1
- ZHQWPWQNVRCXAX-XQQFMLRXSA-N Val-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZHQWPWQNVRCXAX-XQQFMLRXSA-N 0.000 description 1
- OJOMXGVLFKYDKP-QXEWZRGKSA-N Val-Met-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OJOMXGVLFKYDKP-QXEWZRGKSA-N 0.000 description 1
- OFQGGTGZTOTLGH-NHCYSSNCSA-N Val-Met-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N OFQGGTGZTOTLGH-NHCYSSNCSA-N 0.000 description 1
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 1
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 1
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 1
- GVNLOVJNNDZUHS-RHYQMDGZSA-N Val-Thr-Lys Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O GVNLOVJNNDZUHS-RHYQMDGZSA-N 0.000 description 1
- HVRRJRMULCPNRO-BZSNNMDCSA-N Val-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 HVRRJRMULCPNRO-BZSNNMDCSA-N 0.000 description 1
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- -1 antibiotic Substances 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108010010679 lysyl-valyl-leucyl-aspartic acid Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 108010051242 phenylalanylserine Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010037335 tyrosyl-prolyl-glycyl-glycine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of construction methods of biological mutant library.The construction method of biology mutant library disclosed by the invention includes: that DNA fragmentation 1) is imported into target organisms, obtains genetically modified organism;The DNA fragmentation can express the required element for completing rite-directed mutagenesis target DNA in genetically modified organism;2) genetically modified organism is cultivated, biological mutant library is obtained;The biology is mictic organism, and genetically modified organism can the specifically rite-directed mutagenesis target DNA in reproduction cell.The mutant library that benefit is obtained by the present invention can screen the biology with following character: antibiont adverse circumstance, resisting abiotic adverse circumstance, high yield, good quality trait, high secondary metabolites yield etc..Therefore, method of the invention has huge application prospect.
Description
Technical field
The present invention relates in technical field of bioengineering, a kind of construction method of biology mutant library.
Background technique
Gene editing technology, especially CRISPR/Cas9 technology, realize accurately gene editing in biological cell.
Its technical principle is to combine to form RNA by one section of guidance RNA (sgRNA or gRNA) and DNA restriction endonuclease (such as Cas9, Cpf1)
With the compound (abbreviation RNP) of albumen, which can search for the target sequence complementary on guidance RNA in the genome,
So that accurately in the region, the DNA to combination is sheared DNA restriction endonuclease.According to different DNA restriction endonuclease characteristics, cut
The result cut is varied, can be the double-strand DNA cleavage (DSB) of flat end or cohesive end, is also possible to single-strand DNA breaks
(Nick).Organism will lead to insertion to the reparation of DSB or Nick or delete (Indel), to realize to target gene
Precisely editor.
The plant of different editing type seeds can be generated by, which having at present, is directly obtained by transgenic protocol, i.e. agriculture
Bacillus dips in T1 that colored method converts for Arabidopsis plant, or the T0 obtained by the methods of tissue cultures is for plant.Turn base
Because of at high cost, the low efficiency of process, it is difficult largely to obtain this plant that can generate different editing type offsprings.
Summary of the invention
The technical problem to be solved by the present invention is to how prepare mutant library.Largely studies have shown that being directed to certain bits
The reparation for the DSB that point generates is the result is that produce a large amount of different mutation types.In order to the mutated gene for keeping these new
It is enough transmitted to the next generation, specifically starting is practiced shooting in reproduction cell, can theoretically be generated and largely be contained different mutated genes
Offspring individuals.By taking plant as an example, if it is possible to which continual generation is largely with the seed of different mutation types, it will be able to
Establish a mutant seeds library in the site.
In order to solve the above technical problems, being X1 present invention firstly provides a kind of construction method of biological mutant library)
Or X2):
The method X1) include following X11) and X12):
X11 DNA fragmentation) is imported into target organisms, obtains genetically modified organism;The DNA fragmentation can be in the transgenosis
The required element of rite-directed mutagenesis target DNA is completed in expression in biology;
X12 the genetically modified organism) is cultivated, biological mutant library is obtained;
The method X2) include following X21) and X22):
X21 DNA fragmentation) is imported into target organisms, obtains genetically modified organism;The DNA fragmentation can be in the transgenosis
The required element of rite-directed mutagenesis target DNA is completed in expression in biology;
X22 the genetically modified organism) is cultivated, for selecting the target DNA to mutate from the genetically modified organism
Body (being denoted as mutant) obtains biological mutant library, and selection contains the DNA fragmentation and the target from the genetically modified organism
The individual (being denoted as mutant library deposit individual) that mark DNA does not mutate is bred, to expand the mutant library.
The mutant library deposit physical efficiency further generates the individual that the target DNA mutates and containing described
The individual that DNA fragmentation and the target DNA do not mutate, the individual that the target DNA mutates can be used as mutant and return
Enter biological mutant library, it is described containing the DNA fragmentation and individual that the target DNA does not mutate can be used as mutant library
Deposit individual is further used for propagation of mutated body and mutant library deposit individual, and " will generate what the target DNA mutated
Individual and containing the DNA fragmentation and individual that the target DNA does not mutate " this feature heredity go down.By numerous
The mutant library deposit individual is grown, the quantity of mutant in the mutant library is expanded.The number of the breeding can be according to tool
Body it needs to be determined that.
Specifically, the specific site generation mutation (i.e. rite-directed mutagenesis) of the target DNA can be by DNA restriction endonuclease to described
DSB is repaired after target DNA cutting to generate, and is also possible to realize by base deaminase or the enzyme of other changeable bases.
In the above method, the biology can be mictic organism or apomictic organism, as plant, animal, fungi or
Bacterium.
In the above method, the biology is mictic organism, and the genetically modified organism can be specifically fixed in reproduction cell
Target DNA described in point mutation.
The plant can be dicotyledon or monocotyledon.The dicotyledon can be crucifer.
The reproduction cell includes but are not limited to egg cell, egg mother cell, pollen cell or pollen mother cell.
In the above method, at least one in the element is started by reproduction cell specific promoter to be expressed.
In the above method, concretely egg cell specific promoter, pollen cell are special for the reproduction cell specific promoter
Different promoter or meiosis specific promoter.The egg cell specific promoter can be DD45 (SEQ ID NO:6), EC1.1
The promoter, fusion (SEQ ID NO:4) of (SEQ ID NO:3) or EC1.1-1.2.The pollen cell specific promoter is specific
It can be rice Os 08g0560700 promoter (SEQ ID NO:7), tomato LAT52 promoter (SEQ ID NO:8) or arabidopsis
AtSPL(SEQ ID NO:5).The meiosis specific promoter can for arabidopsis AT4G40020 (SEQ ID NO:9),
The promoter of AT4G20900 (SEQ ID NO:10) or AT1G15320 (SEQ ID NO:11) gene.
In the above method, the element can be element needed for CRISPR/Cas method or CRISPR/Cpf1 method.
In the above method, element needed for the CRISPR/Cas method or CRISPR/Cpf1 method may each comprise a1)
Or a2):
A1) DNA restriction endonuclease and sgRNA;
A2) the DNA restriction endonuclease, crRNA and tracrRNA.
The DNA restriction endonuclease can be Cas9, Cas9n, dCas9 or xCas9.Used in the CRISPR/Cpf1 method
DNA restriction endonuclease can be Cpf1.
Specifically, at least a kind of in the DNA restriction endonuclease and the sgRNA start table by reproduction cell specific promoter
Up to can be following a1), a2) or a3):
A1) the DNA restriction endonuclease is started by the reproduction cell specific promoter and is expressed, and the sgRNA is opened by composing type
Mover starting expression;
A2) sgRNA is started by the reproduction cell specific promoter and is expressed, and the DNA restriction endonuclease is made of described
The starting expression of type promoter;
A3) the DNA restriction endonuclease and the sgRNA are started by the reproduction cell specific promoter expresses.
In the above method, the sgRNA targets the target DNA.The target DNA can be the code area of gene,
It can be the control region, such as promoter, enhancer, 5 ' UTR etc. of gene.The expression product of the code area can be albumen
Matter, polypeptide or RNA.
In the above method, the biology is plant, and the reproduction cell specific promoter is egg cell specific promoter,
X22) specific can include: ovum of the selection containing the DNA fragmentation and target DNA mutation from the genetically modified organism
Cell and sperm (sperm can be free of the DNA fragmentation containing the DNA fragmentation) fertilization are formed by individual, as prominent
Variant is selected in the mutant library;Selection is without containing the DNA fragmentation from the genetically modified organism and the target DNA is not sent out
The egg cell of raw mutation and containing the DNA fragmentation and sperm fertilization that the target DNA does not mutate is formed by individual
(being denoted as individual 1) lays in individual as mutant library.
Further, the method is in X22) after include the following steps X23a): select to contain from individual 1 offspring
(sperm can contain the DNA fragmentation also not to the egg cell and sperm that the DNA fragmentation and the target DNA mutate
Containing the DNA fragmentation) being fertilized is formed by individual, it is selected in the mutant library as mutant;From individual 1 offspring
Selection is without containing the DNA fragmentation and the target DNA egg cell not mutated and contains the DNA fragmentation and the target
The sperm fertilization that mark DNA does not mutate is formed by individual, is further used as mutant library deposit individual and is used to prepare mutation
Body and with individual 1 feature can be used as mutant library deposit individual individual.
Repeat step X23a), can in mutant library described in further expansion mutant number.The duplicate number can
For several times, number of repetition is determined according to specific needs.
In the above method, the biology is plant, and the reproduction cell specific promoter is spermatid specific promoter,
X22) specific can include: essence of the selection containing the DNA fragmentation and target DNA mutation from the genetically modified organism
Son is formed by individual with egg cell (egg cell can be free of the DNA fragmentation containing the DNA fragmentation) fertilization, as
Mutant is selected in the mutant library;Selection does not contain the DNA fragmentation and the target DNA not from the genetically modified organism
A sperm of mutation and containing the DNA fragmentation and fertilizing oocytes that the target DNA does not mutate are formed by
Body (is denoted as individual 2), lays in individual as mutant library.
Further, the method is in X22) after include the following steps X23b): select to contain from individual 2 offspring
(egg cell can contain the DNA fragmentation to the sperm that the DNA fragmentation and the target DNA mutate with egg cell
Without the DNA fragmentation) being fertilized is formed by individual, it is selected in the mutant library as mutant;From individual 2 offspring
Middle selection is without containing the DNA fragmentation and the target DNA sperm not mutated and contains the DNA fragmentation and the target
The fertilizing oocytes that do not mutate of mark DNA are formed by individual, be further used as mutant library deposit individual be used to prepare it is prominent
Variant and with individual 2 feature can be used as mutant library deposit individual individual.
Repeat step X23b), can in mutant library described in further expansion mutant number.The duplicate number can
For several times, number of repetition is determined according to specific needs.
In the above method, the DNA fragmentation can contain b1) or b2):
B1 the expression cassette of the DNA restriction endonuclease) can be expressed and the expression cassette of the sgRNA can be expressed;
B2 the expression cassette of the DNA restriction endonuclease) can be expressed, the expression cassette of the crRNA can be expressed and described in capable of expressing
The expression cassette of tracrRNA.
The DNA fragmentation can also express the selection markers that can be used for screening transgenic biology.
The expression cassette is the DNA for referring to express express target protein in host or purpose RNA, which not only may include
The promoter (promoter is denoted as promoter S) for starting destination protein encoding gene or the transcription of purpose RNA encoding gene, may be used also
Terminator including terminating destination protein encoding gene or the transcription of purpose RNA encoding gene.The promoter S can open for composing type
Mover.
The expression cassette that the DNA restriction endonuclease will be expressed and the expression cassette that can express the sgRNA are denoted as expression cassette 1 respectively
With expression cassette 2.When the biology is the plant or the animal, at least one in the expression cassette 1 and the expression cassette 2
Promoter in a expression cassette can be the tissue-specific promoter.
Specifically, the DNA fragmentation also contains and can express the expression cassettes of the selection markers and (expression cassette is denoted as expression
Box 3).
In one embodiment of the invention, the selection markers are Hygromycin resistance marker.Further, the expression cassette
3 contain hygromycin gene.Further, the expression cassette 3 also opening containing the starting hygromycin gene expression
Mover and the terminator for terminating the hygromycin gene expression.
When the DNA fragmentation has contained only the expression cassette 1 and the expression cassette 2, the expression cassette 1 and the expression cassette
2 upstream and downstream sequence is without particular/special requirement, as long as the DNA restriction endonuclease and the sgRNA can be expressed by being able to achieve.Described
When DNA fragmentation contains the expression cassette 1, the expression cassette 2 and the expression cassette 3, the order of connection between each expression cassette is without spy
It is different to require, as long as the DNA restriction endonuclease, the sgRNA and the resistance marker can be expressed by being able to achieve.The DNA piece
Section is also containing the DNA sequence dna for connecting each expression cassette.
In the above method, the target DNA can for biotic stress, abiotic stress, yield traits, quality trait or secondary
Raw metabolin correlation DNA.
The target DNA concretely with biotic stress, abiotic stress, yield traits, quality trait or secondary metabolism
The relevant gene of object.
Further, the biological mutant library can be antibiont adverse circumstance mutant library, resisting abiotic adverse circumstance mutant library, production
Measure character mutant library, quality trait mutant library or secondary metabolites mutant library.
The present invention also protects the method in screening antibiont adverse circumstance, resisting abiotic adverse circumstance, high yield, good quality or high order
Application in raw metabolin mutant.
The biotic stress includes but are not limited to disease, worm, nematode, virus etc..The abiotic stress includes but not only
It is limited to herbicide, antibiotic, insecticide, fungicide, drought, flood, cold, heat, salt, heavy metal etc..
The present invention provides a kind of construction methods of biological mutant library, and this method is by that will express completion rite-directed mutagenesis
The DNA fragmentation of the required element of target DNA imports in target organisms, has obtained a kind of genetically modified organism.When target organisms are to have
The sexual reproduction biochron, the promoter of at least one element is that reproduction cell is special in the required element of rite-directed mutagenesis target DNA
Promoter, therefore, obtained genetically modified organism specifically can carry out rite-directed mutagenesis to target DNA in reproduction cell, according to
The genotype and target practice situation of female and male gametophyte, and then the offspring with different genotype is obtained, occur including target gene
The transgenic progeny that the non-transgenic offspring and target DNA that offspring, the target DNA of mutation do not mutate do not mutate.
The offspring that target gene mutates can be used for screening the individual containing objective trait, and what target DNA did not mutated turns base
Because offspring will continue rite-directed mutagenesis to target DNA in reproduction cell and reach its offspring, while it can also generate target
The transgenic progeny that mark DNA does not mutate.This process can pass on from generation to generation, and during breeding, and every Dai Junke is produced
The plant that raw a large amount of target DNA mutate, and it is mutated multiplicity, and then the prominent of a large amount of target DNA mutations can be formulated
The generation process in variant library, plant mutant library is as shown in Figure 1.It, can be from obtained mutant library according to the difference of target DNA
Middle screening has the biology of following character: antibiont adverse circumstance, resisting abiotic adverse circumstance, high yield, good quality trait, high secondary metabolism
Produce amount etc..Therefore, method of the invention has huge application prospect.
Detailed description of the invention
Fig. 1 shows the generation process in plant mutant library;
Fig. 2, which is shown, extracts 13 plants of T1 for the DNA of plant, and the knot of PCR amplification and sequencing is carried out for the target area of ALS
Fruit;
Fig. 3, which is shown, screens a large amount of antiweed mutant;
Fig. 4 shows the DNA of 17 plants of antiweed plant, carries out the result of PCR sequencing.
Specific embodiment
The present invention is further described in detail With reference to embodiment, and the embodiment provided is only for explaining
The bright present invention, the range being not intended to be limiting of the invention.Experimental method in following embodiments is unless otherwise specified
Conventional method.Material as used in the following examples, reagent, instrument etc., are commercially available unless otherwise specified.
Quantitative test in following embodiment, is respectively provided with three repeated experiments, and results are averaged.
The building of embodiment 1. is directed to the knockout carrier of arabidopsis als gene, Cas9 gene specifically expressing in egg cell.
Wherein, target spot isttgccgatgatcccgagtgg, arabidopsis als gene DNA is shown in SEQ ID NO:1,
Amino acid sequence is shown in SEQ ID NO:2.
By DNA fragmentation 5 'ttgccgatgatcccgagtgg3 ' be cloned into pHEE401E carrier refer to (1) Xing H L,
Dong L,Wang Z P,et al.A CRISPR/Cas9toolkit for multiplex genome editing in
plants[J].BMC Plant Biology,2014,14(1):327.(2)Wang Z P,Xing H L,Dong L,et
al.Egg cell-specific promoter-controlled CRISPR/Cas9 efficiently generates
homozygous mutants for multiple target genes in Arabidopsis in a single
2015,16 (1): generation [J] .Genome Biology in the sgRNA expression cassette in 144. }, is transferred to Agrobacterium
In GV3101, with for use by dipping in colored method arabidopsis thaliana transformation.
Embodiment 2. is converted { the part method therefor and material, with reference to (3) Chen Y, Wang Z, Ni to arabidopsis
H,Xu Y,Chen Q,Jiang L.2017.CRISPR/Cas9-mediated base-editing system
efficiently generates gain-of-function mutations in Arabidopsis.Science China
Life Sciences 60,520-523.}
After the carrier built is transformed into Agrobacterium GV3101 bacterial strain by freeze-thaw method, bacterium solution is passed through into method of scoring
(containing kanamycin and gentamicin) is applied in YEP solid medium, after cultivating 36-48h under 28 DEG C of dark surrounds, picking
Single colonie is inoculated in being added in the liquid YEB culture medium of kanamycins and gentamicin of 1ml, and overnight (28 DEG C of shaken cultivation
200rpm).Bacterium colony PCR identification is carried out at this time, and chooses wherein positive colony, is added in 50ml conical flask, and 25ml is added
YEP fluid nutrient medium (containing kanamycin and gentamicin), shake culture under conditions of 28 DEG C of 200rpm, until OD600
Value is increased in 0.8-1.0.Bacterium solution centrifugation is taken to remove supernatant, and with 5% sucrose solution (100ml of same volume
Aseptic deionized water adds 5g sucrose) thallus is resuspended, and SilwetL-77 (0.02%) is added in bacterium solution and mixes.It is quasi- by be suitable for
After southern mustard inflorescence dips 0.5-1min in bacterium solution, black opaque-plastic bag is covered on arabidopsis seedling, creates dark item
Part is placed in 22 DEG C of hot-house cultures and is transferred to illumination cultivation afterwards for 24 hours, harvests seed after seed is mature.The arabidopsis seed of harvest
After disinfection, the screening transgenic plant on the MS culture medium containing hygromycin (25mg/L).Extract T1 for plant DNA,
PCR amplification is carried out for the target area of ALS and is sequenced.
Embodiment 3. identifies T1 for the genotype of plant
It is sequenced by PCR product and hygromycin resistance screens the editing type determined to als gene, while separating tool
There is T-DNA and als gene plant (magic seed plant) not to be edited.
As shown in Figure 1, type there are two types of the egg cells that transgenic plant generates, ratio 1:1, the first genotype is to contain
There is T-DNA (DNA fragmentation for completing the required element of rite-directed mutagenesis target DNA can be expressed in the genetically modified organism),
Due to the specifically expressed characteristic of egg cell, the target gene on genome will be edited and (be mutated), second of genotype
It is not contain T-DNA, therefore the target gene on genome is not edited, and is still wild type.The genotype of pollen is also same
There are two types of samples, ratio 1:1, the first genotype is containing T-DNA, due to the specifically expressed characteristic of egg cell, on genome
Target gene will not be edited, be still wild type, second of genotype be, does not contain T-DNA, the target gene on genome
For wild type.After the plant selfing, there are four types of different genotype, ratio 1:1:1:1 for the seed tool of harvest.The first gene
Type is the T-DNA copied containing one and contains edited target gene;Second of genotype is containing there are two copies
T-DNA and contain edited target gene;The third genotype is without containing T-DNA and not contain edited target spot
Gene, i.e. WT lines;4th kind of genotype is the T-DNA copied containing one and does not contain edited target spot base
Cause.The plant of 4th kind of genotype is identical with female genotype in generation, and the probability of appearance is 1/4, if sieved to T-DNA
(pass through hygromycin selection) if choosing, then its probability occurred is 1/3.These plant can pass through the sequencing to target gene
It picks out.The individual for having 1/2 is also contained into edited target gene in the offspring that these plant generate, 1/4 is wild
Type, 1/4 is mother for genotype.The process can be gone down with Infinite Cyclic.This seed with the 4th kind of genotype can generate
With the identical seed of oneself genotype, additionally it is possible to generate seed more with independent mutation events, therefore from one
Seed starts that one can be established to may include unlimited individual mutant library, and the seed of this genotype is named as " magic kind
Son ".In addition, not editing target gene containing T-DNA and containing an editor and one according to the technical principle of " magic seed "
Plant, can continue to generate in offspring and a large amount of independent update event.
13 plants of T1 are extracted for the DNA of plant, PCR amplification is carried out for the target area of ALS and is sequenced.The result shows that about
70% T1 plant produces mutation in the desired location of ALS, as shown in Figure 2.
The characteristic specifically practiced shooting using egg cell it is found that these T1 plant when generating seed (T2 generation), can be to not
The site ALS of editor re-starts editor, independent to generate new mutation type.Again technical principle (also known as " the magic kind practiced shooting
Son " system) as shown in Figure 1.
Embodiment 4. screens antiweed mutant
The technology path of " magic seed " is utilized, T2 the mutant of antiweed occurs for seed.
By from above-mentioned T1 for the T2 harvested on plant for seed, be taped against after disinfection containing 0.24mg/L AC 263222
On MS culture medium, antiweed mutant is screened, as shown in figure 3, successfully screening a large amount of antiweed plant.
The random DNA for extracting wherein 17 plants of antiweed plant, PCR sequencing show that the als gene of these plant has occurred
Gene mutation as shown in Figure 4.
The all publications and patents application referred in specification is both incorporated herein by reference, such as every publication or
Patent application individually, is particularly incorporated herein by reference the same.
Although the mode of aforementioned invention by way of illustration and example carries out in more detail for the sake of being clearly understood that
Description, but it will be apparent that can implement certain changes and modification within the scope of the appended claims, it is such to change
Become and modification is all within the scope of the present invention.
Sequence table
<110>Qingdao Qing Yuan compound Co., Ltd
<120>a kind of construction method of biological mutant library
<130> 20190403
<150> 2018104006077
<151> 2018-04-28
<160> 11
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2013
<212> DNA
<213>arabidopsis als gene DNA sequence dna (ALS)
<400> 1
atggcggcgg caacaacaac aacaacaaca tcttcttcga tctccttctc caccaaacca 60
tctccttcct cctccaaatc accattacca atctccagat tctccctccc attctcccta 120
aaccccaaca aatcatcctc ctcctcccgc cgccgcggta tcaaatccag ctctccctcc 180
tccatctccg ccgtgctcaa cacaaccacc aatgtcacaa ccactccctc tccaaccaaa 240
cctaccaaac ccgaaacatt catctcccga ttcgctccag atcaaccccg caaaggcgct 300
gatatcctcg tcgaagcttt agaacgtcaa ggcgtagaaa ccgtattcgc ttaccctgga 360
ggtgcatcaa tggagattca ccaagcctta acccgctctt cctcaatccg taacgtcctt 420
cctcgtcacg aacaaggagg tgtattcgca gcagaaggat acgctcgatc ctcaggtaaa 480
ccaggtatct gtatagccac ttcaggtccc ggagctacaa atctcgttag cggattagcc 540
gatgcgttgt tagatagtgt tcctcttgta gcaatcacag gacaagtccc tcgtcgtatg 600
attggtacag atgcgtttca agagactccg attgttgagg taacgcgttc gattacgaag 660
cataactatc ttgtgatgga tgttgaagat atccctagga ttattgagga agctttcttt 720
ttagctactt ctggtagacc tggacctgtt ttggttgatg ttcctaaaga tattcaacaa 780
cagcttgcga ttcctaattg ggaacaggct atgagattac ctggttatat gtctaggatg 840
cctaaacctc cggaagattc tcatttggag cagattgtta ggttgatttc tgagtctaag 900
aagcctgtgt tgtatgttgg tggtggttgt ttgaattcta gcgatgaatt gggtaggttt 960
gttgagctta cggggatccc tgttgcgagt acgttgatgg ggctgggatc ttatccttgt 1020
gatgatgagt tgtcgttaca tatgcttgga atgcatggga ctgtgtatgc aaattacgct 1080
gtggagcata gtgatttgtt gttggcgttt ggggtaaggt ttgatgatcg tgtcacgggt 1140
aagcttgagg cttttgctag tagggctaag attgttcata ttgatattga ctcggctgag 1200
attgggaaga ataagactcc tcatgtgtct gtgtgtggtg atgttaagct ggctttgcaa 1260
gggatgaata aggttcttga gaaccgagcg gaggagctta agcttgattt tggagtttgg 1320
aggaatgagt tgaacgtaca gaaacagaag tttccgttga gctttaagac gtttggggaa 1380
gctattcctc cacagtatgc gattaaggtc cttgatgagt tgactgatgg aaaagccata 1440
ataagtactg gtgtcgggca acatcaaatg tgggcggcgc agttctacaa ttacaagaaa 1500
ccaaggcagt ggctatcatc aggaggcctt ggagctatgg gatttggact tcctgctgcg 1560
attggagcgt ctgttgctaa ccctgatgcg atagttgtgg atattgacgg agatggaagc 1620
tttataatga atgtgcaaga gctagccact attcgtgtag agaatcttcc agtgaaggta 1680
cttttattaa acaaccagca tcttggcatg gttatgcaat gggaagatcg gttctacaaa 1740
gctaaccgag ctcacacatt tctcggggat ccggctcagg aggacgagat attcccgaac 1800
atgttgctgt ttgcagcagc ttgcgggatt ccagcggcga gggtgacaaa gaaagcagat 1860
ctccgagaag ctattcagac aatgctggat acaccaggac cttacctgtt ggatgtgatt 1920
tgtccgcacc aagaacatgt gttgccgatg atcccgagtg gtggcacttt caacgatgtc 1980
ataacggaag gagatggccg gattaaatac tga 2013
<210> 2
<211> 670
<212> PRT
<213>arabidopsis als gene amino acid sequence (ALS)
<400> 2
Met Ala Ala Ala Thr Thr Thr Thr Thr Thr Ser Ser Ser Ile Ser Phe
1 5 10 15
Ser Thr Lys Pro Ser Pro Ser Ser Ser Lys Ser Pro Leu Pro Ile Ser
20 25 30
Arg Phe Ser Leu Pro Phe Ser Leu Asn Pro Asn Lys Ser Ser Ser Ser
35 40 45
Ser Arg Arg Arg Gly Ile Lys Ser Ser Ser Pro Ser Ser Ile Ser Ala
50 55 60
Val Leu Asn Thr Thr Thr Asn Val Thr Thr Thr Pro Ser Pro Thr Lys
65 70 75 80
Pro Thr Lys Pro Glu Thr Phe Ile Ser Arg Phe Ala Pro Asp Gln Pro
85 90 95
Arg Lys Gly Ala Asp Ile Leu Val Glu Ala Leu Glu Arg Gln Gly Val
100 105 110
Glu Thr Val Phe Ala Tyr Pro Gly Gly Ala Ser Met Glu Ile His Gln
115 120 125
Ala Leu Thr Arg Ser Ser Ser Ile Arg Asn Val Leu Pro Arg His Glu
130 135 140
Gln Gly Gly Val Phe Ala Ala Glu Gly Tyr Ala Arg Ser Ser Gly Lys
145 150 155 160
Pro Gly Ile Cys Ile Ala Thr Ser Gly Pro Gly Ala Thr Asn Leu Val
165 170 175
Ser Gly Leu Ala Asp Ala Leu Leu Asp Ser Val Pro Leu Val Ala Ile
180 185 190
Thr Gly Gln Val Pro Arg Arg Met Ile Gly Thr Asp Ala Phe Gln Glu
195 200 205
Thr Pro Ile Val Glu Val Thr Arg Ser Ile Thr Lys His Asn Tyr Leu
210 215 220
Val Met Asp Val Glu Asp Ile Pro Arg Ile Ile Glu Glu Ala Phe Phe
225 230 235 240
Leu Ala Thr Ser Gly Arg Pro Gly Pro Val Leu Val Asp Val Pro Lys
245 250 255
Asp Ile Gln Gln Gln Leu Ala Ile Pro Asn Trp Glu Gln Ala Met Arg
260 265 270
Leu Pro Gly Tyr Met Ser Arg Met Pro Lys Pro Pro Glu Asp Ser His
275 280 285
Leu Glu Gln Ile Val Arg Leu Ile Ser Glu Ser Lys Lys Pro Val Leu
290 295 300
Tyr Val Gly Gly Gly Cys Leu Asn Ser Ser Asp Glu Leu Gly Arg Phe
305 310 315 320
Val Glu Leu Thr Gly Ile Pro Val Ala Ser Thr Leu Met Gly Leu Gly
325 330 335
Ser Tyr Pro Cys Asp Asp Glu Leu Ser Leu His Met Leu Gly Met His
340 345 350
Gly Thr Val Tyr Ala Asn Tyr Ala Val Glu His Ser Asp Leu Leu Leu
355 360 365
Ala Phe Gly Val Arg Phe Asp Asp Arg Val Thr Gly Lys Leu Glu Ala
370 375 380
Phe Ala Ser Arg Ala Lys Ile Val His Ile Asp Ile Asp Ser Ala Glu
385 390 395 400
Ile Gly Lys Asn Lys Thr Pro His Val Ser Val Cys Gly Asp Val Lys
405 410 415
Leu Ala Leu Gln Gly Met Asn Lys Val Leu Glu Asn Arg Ala Glu Glu
420 425 430
Leu Lys Leu Asp Phe Gly Val Trp Arg Asn Glu Leu Asn Val Gln Lys
435 440 445
Gln Lys Phe Pro Leu Ser Phe Lys Thr Phe Gly Glu Ala Ile Pro Pro
450 455 460
Gln Tyr Ala Ile Lys Val Leu Asp Glu Leu Thr Asp Gly Lys Ala Ile
465 470 475 480
Ile Ser Thr Gly Val Gly Gln His Gln Met Trp Ala Ala Gln Phe Tyr
485 490 495
Asn Tyr Lys Lys Pro Arg Gln Trp Leu Ser Ser Gly Gly Leu Gly Ala
500 505 510
Met Gly Phe Gly Leu Pro Ala Ala Ile Gly Ala Ser Val Ala Asn Pro
515 520 525
Asp Ala Ile Val Val Asp Ile Asp Gly Asp Gly Ser Phe Ile Met Asn
530 535 540
Val Gln Glu Leu Ala Thr Ile Arg Val Glu Asn Leu Pro Val Lys Val
545 550 555 560
Leu Leu Leu Asn Asn Gln His Leu Gly Met Val Met Gln Trp Glu Asp
565 570 575
Arg Phe Tyr Lys Ala Asn Arg Ala His Thr Phe Leu Gly Asp Pro Ala
580 585 590
Gln Glu Asp Glu Ile Phe Pro Asn Met Leu Leu Phe Ala Ala Ala Cys
595 600 605
Gly Ile Pro Ala Ala Arg Val Thr Lys Lys Ala Asp Leu Arg Glu Ala
610 615 620
Ile Gln Thr Met Leu Asp Thr Pro Gly Pro Tyr Leu Leu Asp Val Ile
625 630 635 640
Cys Pro His Gln Glu His Val Leu Pro Met Ile Pro Ser Gly Gly Thr
645 650 655
Phe Asn Asp Val Ile Thr Glu Gly Asp Gly Arg Ile Lys Tyr
660 665 670
<210> 3
<211> 1262
<212> DNA
<213>EC1.1 promoter (EC1.1)
<400> 3
cgatttcttc ttcctctgtt cttcggcgtt caatttctgg ggttttctct tcgttttctg 60
taactgaaac ctaaaatttg acctaaaaaa aatctcaaat aatatgattc agtggttttg 120
tacttttcag ttagttgagt tttgcagttc cgatgagata aaccaatacc atggactttg 180
ataaatgttc ctcgctgacg taagaagaca ttagtaatgg ttataatata tagctttcta 240
tgaatgtatg gtgagaaaat gtctgttcac tgattttgag tttggaataa aagcatttgc 300
gtttggttta tcattgcgtt tatacaagga cagagatcca ctgagctgga atagcttaaa 360
accattatca gaacaaaata aaccattttt tgttaagaat cagagcatag taaacaacag 420
aaacaaccta agagaggtaa cttgtccaag aagatagcta attatatcta ttttataaaa 480
gttatcatag tttgtaagtc acaaaagatg caaataacag agaaactagg agacttgaga 540
atatacattc ttgtatattt gtattcgaga ttgtgaaaat ttgaccataa gtttaaattc 600
ttaaaaagat atatctgatc tagatgatgg ttatagactg taattttacc acatgtttaa 660
tgatggatag tgacacacat gacacatcga caacactata gcatcttatt tagattacaa 720
catgaaattt ttctgtaata catgtctttg tacataattt aaaagtaatt cctaagaaat 780
atatttatac aaggagttta aagaaaacat agcataaagt tcaatgagta gtaaaaacca 840
tatacagtat atagcataaa gttcaatgag tttattacaa aagcattggt tcactttctg 900
taacacgacg ttaaaccttc gtctccaata ggagcgctac tgattcaaca tgccaatata 960
tactaaatac gtttctacag tcaaatgctt taacgtttca tgattaagtg actatttacc 1020
gtcaatcctt tcccattcct cccactaatc caacttttta attactctta aatcaccact 1080
aagcttcgaa tccatccaaa accacaatat aaaaacagaa ctctcgtaac tcaatcatcg 1140
caaaacaaaa caaaacaaaa caaaaacccc aaaaagaaag aataagctag atggattaca 1200
aggaccacga cggggattac aaggaccacg acattgatta caaggatgat gatgacaaga 1260
tg 1262
<210> 4
<211> 1614
<212> DNA
<213>EC1.1-1.2 promoter, fusion (EC1.1-1.2)
<400> 4
cgatttcttc ttcctctgtt cttcggcgtt caatttctgg ggttttctct tcgttttctg 60
taactgaaac ctaaaatttg acctaaaaaa aatctcaaat aatatgattc agtggttttg 120
tacttttcag ttagttgagt tttgcagttc cgatgagata aaccaatacc atggttatac 180
tagtgaataa aagcatttgc gtttggttta tcattgcgtt tatacaagga cagagatcca 240
ctgagctgga atagcttaaa accattatca gaacaaaata aaccattttt tgttaagaat 300
cagagcatag taaacaacag aaacaaccta agagaggtaa cttgtccaag aagatagcta 360
attatatcta ttttataaaa gttatcatag tttgtaagtc acaaaagatg caaataacag 420
agaaactagg agacttgaga atatacattc ttgtatattt gtattcgaga ttgtgaaaat 480
ttgaccataa gtttaaattc ttaaaaagat atatctgatc taggtgatgg ttatagactg 540
taattttacc acatgtttaa tgatggatag tgacacacat gacacatcga caacactata 600
gcatcttatt tagattacaa catgaaattt ttctgtaata catgtctttg tacataattt 660
aaaagtaatt cctaagaaat atatttatac aaggagttta aagaaaacat agcataaagt 720
tcaatgagta gtaaaaacca tatacagtat atagcataaa gttcaatgag tttattacaa 780
aagcattggt tcactttctg taacacgacg ttaaaccttc gtctccaata ggagcgctac 840
tgattcaaca tgccaatata tactaaatac gtttctacag tcaaatgctt taacgtttca 900
tgattaagtg actatttacc gtcaatcctt tcccattcct cccactaatc caacttttta 960
attactctta aatcaccact aagctagtaa cgcctatcat gaattagctc tactaaatct 1020
agcaaccttt caaatttgca gtattgcagg tgtctctgtg tctttaaaat agttgcctta 1080
tgatttcttc ggtttcaaga tgatcaaata gttatagatt tcatgctcac acatgctcat 1140
tagatgtgta catactttac ttacccaaat ctattttctc gcaaagattt tgatggtaaa 1200
gctgatttgg ttctattgaa ctaaatcaaa cgagtttcag actgagtgat tctaatccgg 1260
cccattagcc cctaaacaga cccactaatt acgcagcttt taatagagta attacaccta 1320
gtttacccac taaaccacta agcactaatt atctcacaat ctaatgagct tccctcgtaa 1380
ttacttgggc tttcactcta ccatttattt gtaacagtca agtctctact gtctctatat 1440
aaactctcta aagttaacac acaattctca tcacaaacaa atcaaccaaa gcaacttcta 1500
ctctttcttc tttcgacctt atcaatctgt tgagaaatct agatggatta caaggaccac 1560
gacggggatt acaaggacca cgacattgat tacaaggatg atgatgacaa gatg 1614
<210> 5
<211> 2016
<212> DNA
<213>AtSPL promoter (AtSPL)
<400> 5
ggatccgttt gtttgttttt taatcgtttt catcaacatg attgatatat atatagtttt 60
tgcacttgaa aaagttttga tttttattta tgtaaaaaac tgcagaagaa acgtttggat 120
ggtgatcaga ataatgtagt tcgatccaac ggtggtggat tttcgaaata cacaatgatt 180
cctcctccga tgaacggcta cgatcagtat cttcttcaat cagatcatca tcagaggagc 240
caaggtttcc tttatgatca tagaatcgct agagcagctt cagtttctgc ttctagtact 300
actattaatc cttatttcaa cgaggcaaca aatcatacgg tactaagtat agtccattta 360
ttaatactca tatataggta tatatgtata taactgttga tcttatttga tttaactggt 420
gggtttaggg accaatggag gaatttggga gctacatgga aggaaaccct agaaatggat 480
caggaggtgt gaaggagtac gagttttttc cggggaaata tggtgaaaga gtttcagtgg 540
tggctaaaac gtcgtcactc gtaggtgatt gcagtcctaa taccattgat ttgtccttga 600
agctttaaat gttttatctt tctatattga tttaaacaaa atcgtctctt taaagaaaaa 660
acattttaag tagatgaaag taagaaacag aagaaaaaaa agagagagcc ttttttggtg 720
tatgcatctg agagctgagt cgaaagaaag attcagcttt tggattaccc ttttggttgt 780
ttattatgag attctaacct aaacactcag acatatatgt tctgttctct tccttaattg 840
ttgtcatgaa acttctctct ccctctctct ctctaaagtt gtgtcagatc ttggggcttg 900
tatccatttt gtgtttcttt agttaggcaa tgatcctgtc atgattcatg ttatcaccta 960
attaatcctc ggttttcgaa acggtgtcat gcatatctga ttaatcttgt tatctggtgt 1020
gagataaatg tatcaaattg ctcttgttta tagcttttcc aattaatgtc attgcatagc 1080
atatgggatg tacagcttcg ttttcgattt ataaaattta tacatgtgtt tggtacgtac 1140
tgttttgttt tggatcagaa ttataaattt agtacagtat aaactacttt aaaaattggc 1200
caatgagaat tttgagttta tcttcttttt ataagttgat tgattttgct ttgtttattt 1260
atagaaaata tgaaatttta tcaattattt ttgggatgct tttttattga ttttagttcg 1320
gctaaaatta gttagatgtt taaatttatt aaaacagata tgcaaaaatt aactcgatgg 1380
tttttttttt tttttttagg gggataaaaa tcgaactata tagttaatta aaacttaaaa 1440
tgtttttctg aacggctatt tcactgattt tttagtagtt taaatgtttt tcaccgaaaa 1500
taaaaacaga ataggaaaca atactataga agtctaacca aaaaaagttc aatatccagt 1560
agttcaatat ttctaaaaag aaaatttcta cacaaagttt atggcaaaaa cctaagttat 1620
tatggagaaa accaagttat tgaaagttat agcgtactgt atgtacaatc tttcatcgtg 1680
atttcatgta ttatagataa aattattcat tgtggatgta atgcaaatag aaccatccgt 1740
aaatccatgt attacggaaa aattattcat cacaactctt atgtttgaaa atagttagat 1800
tcggtcttag atcattattt taaaaataca aataaacaaa tacgatcgac aacaattgct 1860
cagcaaattt gacatactga taaagtcatt gtttgacaaa acacatatgg gccttaatat 1920
caaaacacac ggcccattat aaaagtaaac tgataagata aaacagttcc ctatgattcc 1980
tcaataagca gctgctcagc acgttctcgt ggtacc 2016
<210> 6
<211> 1020
<212> DNA
<213>DD45 promoter (DD45)
<400> 6
aaatgttcct cgctgacgta agaagacatt agtaatggtt ataatatata gctttctatg 60
aatgtatggt gagaaaatgt ctgttcactg attttgagtt tggaataaaa gcatttgcgt 120
ttggtttatc attgcgttta tacaaggaca gagatccact gagctggaat agcttaaaac 180
cattatcaga acaaaataaa ccattttttg ttaagaatca gagcatagta aacaacagaa 240
acaacctaag agaggtaact tgtccaagaa gatagctaat tatatctatt ttataaaagt 300
tatcatagtt tgtaagtcac aaaagatgca aataacagag aaactaggag acttgagaat 360
atacattctt gtatatttgt attcgagatt gtgaaaattt gaccataagt ttaaattctt 420
aaaaagatat atctgatcta gatgatggtt atagactgta attttaccac atgtttaatg 480
atggatagtg acacacatga cacatcgaca acactatagc atcttattta gattacaaca 540
tgaaattttt ctgtaataca tgtctttgta cataatttaa aagtaattcc taagaaatat 600
atttatacaa ggagtttaaa gaaaacatag cataaagttc aatgagtagt aaaaaccata 660
tacagtatat agcataaagt tcaatgagtt tattacaaaa gcattggttc actttctgta 720
acacgacgtt aaaccttcgt ctccaatagg agcgctactg attcaacatg ccaatatata 780
ctaaatacgt ttctacagtc aaatgcttta acgtttcatg attaagtgac tatttaccgt 840
caatcctttc ccattcctcc cactaatcca actttttaat tactcttaaa tcaccactaa 900
gcttcgaatc catccaaaac cacaatataa aaacagaact ctcgtaactc aatcatcgca 960
aaacaaaaca aaacaaaaca aaaaccccaa aaagaaagaa taatggcttc taacacaagt 1020
<210> 7
<211> 263
<212> DNA
<213>rice Os 08g0560700 promoter (Os08g0560700)
<400> 7
aaaaagggga tcgagaggaa gaggaagctt tgtgagtttg ggcctttatt tggtggaggc 60
ccattgattc ctacgtgggc tgggccgaac acggtccagg tagttggtcc acattccagg 120
ttgaacgatt ccagcggcgg cggcgagtgg tggcgcgcga tcatctccca ctcccaccgt 180
tgttcctcct caacacgcgc cactcctcac attcatttcc acctgctcat ctatatctat 240
ctatcatcaa gctgatcatc cat 263
<210> 8
<211> 603
<212> DNA
<213>tomato LAT52 promoter (LAT52)
<400> 8
tgtcgacata ctcgactcag aaggtattga ggaatgatcg attctgggtc atttgtgtgg 60
ttaatcaccc tccaaatcaa ctaagtcatc ctgaaggaca atatcctatt ttttctctcg 120
taggtttatc atttaaatta ctatcgcgtg ataattttgt aacgtagaaa aataatacca 180
ttaatccaaa cgttatattc attaaaataa ttatgataca tttaaaaata tttcgtgacc 240
tctcaattat tgcaaattct aagccatccc aagttttgag gctaattttt tttactatac 300
tatttttaca accacaaaaa cataaaaaat aaaaaataaa aaaaataaac cgagtcaatt 360
gctacaatca cttcattatt aattttaatt aatattatgt ggttatatat gaaactgtta 420
gagaaataat agctccacca tatttttttc tcaatttatt ttcactataa aaaggctatt 480
tcattataat caaaacaaga cacacacaaa gagaaggagc aataaaataa aagtaaacaa 540
caatttgtgt gtttaaaaaa aaaaaaaaag tacacacacc aaaaaaaaaa attccaattt 600
aaa 603
<210> 9
<211> 1553
<212> DNA
<213>AT4G40020 promoter (AT4G40020)
<400> 9
ggggtttagg tctttccatt actttttaat gttttttctg ttactgtctc cgcgatctga 60
ttttacgaca atagagtttc gggttttgtc ccattccagt ttgaaaataa aggtccgtct 120
tttaagtttg ctggatcgat aaacctgtga agattgagtc tagtcgattt attggatgat 180
ccattcttca tcgttttttt cttgcttcga agttctgtat aaccagattt gtctgtgtgc 240
gattgtcatt acctagccgt gtatcgagaa ctagggtttt cgagtcaatt ttgccccttt 300
tggttatatc tggttcgata acgattcatc tggattaggg ttttaagtgg tgacgtttag 360
tattccaatt tcttcaaaat ttagttatgg ataatgaaaa tccccaattg actgttcaat 420
ttcttgttaa atgcgcagat ggctcgtacc aagcaaaccg ctcgtaagtc caccggaggt 480
aaagctccaa ggaagcaact tgctactaag gttttgttcc ttcttgtctc ttttttcaaa 540
taatacttgt gttgtgaagt tgaatgttaa tctccttctt tattaacctc aggctgctcg 600
taaatctgca ccaactactg gtggagtcaa gaaaccacat cgttaccgtc ctggaactgt 660
tgctctccgg tttgtccctt cttcgatttg tatgtgattc tttgagatta tgtaacattg 720
tgtgttaaca ttcctcttat cttttggtgt tcagtgaaat ccgtaagtac cagaagagta 780
ctgagttgct tatcaggaaa ctgccatttc agaggctagt ccgtgagatt gctcaagatt 840
tcaagactga tttgcgtttc cagagccatg ctgtcttagc tctccaggaa gctgcagaag 900
catatcttgt tggtctcttt gaagacacta acctttgtgc cattcatgcc aagcgtgtga 960
ccataatgcc caaagacatt cagctcgctc gtcgtatcag aggtgaacgc gcttaagcca 1020
accaagaatc cgagatttgg ttcaagtagt ttttgttttt tatgaaagca agatcttaat 1080
tgctgtgttt tttaaatctc tgggtatgta gtagtaagag tagtaagaag tctgcaatct 1140
aagaatgttg tgttctttaa gcttattatt atgtgtgttg cgaactcttt ttaactcttt 1200
tgttaaattc ttatgttttc ttaactcgtt tgttcgtcac cattgctttc tcttcaaata 1260
atggctgatt tttttctata attttggatt tgttgaatgc tttcttttaa aagaatcaga 1320
ttttggactt ttgaccaaag aaaataataa tatcagacga taaaatagac ggctctcgat 1380
aaaactaacc ctaaaaataa ggaaataagt tcctctttga accaaatttt ctttctttga 1440
ccaatagatc tttttgtcaa cctcttaaat atattcttag tcaatcttct aataaaccca 1500
ttggccatta ccaaaaattc ctcggaaacg ctgaataaaa aacattctat cat 1553
<210> 10
<211> 621
<212> DNA
<213>AT4G20900 promoter (AT4G20900)
<400> 10
ctcggcaaac gccataacta cagcgtcgag tttagcggtg ttggtgggtc tggtgaagta 60
gaacccggat ttgcttctca gatagctatt tttagacggg aagcttcatc tgttgagaat 120
gttgcagaaa gctcaatgca gccttataaa gtcatctggg agtggaagaa agaagatgta 180
gaaaagaaaa agactgatct ttgactagag tagtatctac cagagaatat atatattgca 240
agcaatgtga tgacgtgttc atctataaaa ctcaaagctc gtttagttct tttgccatga 300
gcttttgcag attaaccata aaatcgaacc tttatgttta caagatcctt ttgtctccaa 360
gtctactggt ccgttgaagt ttaaagatta gatcagtaga ttaccctttt tgcccctacg 420
ttaaagtttg tttatttaaa tacaagtcct tgtgattttt atcactttct cacttcttca 480
acgacactga ttcgttttca aagcatttgc gttcttgatc tttttcacga gggcgatttc 540
tgaagaacac gagaatttga attctgggaa aagctttctc gaactttatc tgagtaaatt 600
gacagagaga atcgaaaaag a 621
<210> 11
<211> 1320
<212> DNA
<213>AT1G15320 promoter (AT1G15320)
<400> 11
caactcacca cctccctctc cttccccgaa gttttctcgg tgaactccag agctgtgagt 60
ggcagccacg tttgcaactc cggtaggcga catcctttca aatcagttgc tgaaaacgta 120
cctatcactt ttctatgtct cccctgcaat ctcaaaaaac acaaaatgag taaacattat 180
atattaacca aagtatatat gtaaaatgaa gcctacattg actagctgca gatgatcctc 240
ttgtgctata tcaggtgcat gaacgatggg gacagcgttg agcagagcac ccttcataac 300
gttgatggca ttggaaacag tggttctctc tgtgatggcg taaacggaat cattaacagc 360
tccgagatca gagatggagc gtgagagaac agttttgagg tcatcaaagt gatggtcttt 420
aaggaaacgc aagagatcca tctgagtaag catcttgtaa gcagaggcag actcaatcaa 480
ctcaactcct gcaatagtgt tattgctctc tatgctgctc tccactggca ctaaagctcg 540
atggatccct ttgctaaaca cttccatgca ctctaacacg ctggtattag gattcagtgt 600
ccagagactg agtccttcga ggcaatgacc gatgatggat gacacctgtg aactcatctt 660
gcgatcaaga tcagagagat tggaatcttc accggcgata tgagcaagta tgtcaagcat 720
cgtgagaatc ccgatatagt gttttcttac aactccagtt tgtttgtctg attccatgat 780
catggaacca ccggctccga tccagtggcc tggaggtgca gccactggga gggctgagat 840
ggagttagcc accaatgtgt tcattgcgtg ggaaagtgta gccgtgtatg gtacctcgac 900
gagccgtcgg tttctgaccg ttagatcttt ggccgtgaca ttgatcagac ggctgtgatc 960
ttctttgctc ttctcttctt gcatagtgtt ctactactgt tgtcgtagct tgaacttgtt 1020
gctttgagaa cctttttaag tgtcgatctt ggctcgaaat ttgatgtgaa tggatcagga 1080
cgccgtgtga tgatgatcta gaagcacgtg gcaatcgata cttgctaatg acatgcaaca 1140
cgtggcattt ttcattgggc cttagctaac ggcccagtag tatgtttaat gacccaaata 1200
acccttcgtc tctgctttgt ttttatttct taaaatcagt atctccctcg cgtccgcaaa 1260
tgaaacgacc tgagaatcca agaacgtagg aaagaaatca gtgctgaaga agaaacacga 1320
Claims (10)
1. a kind of construction method of biology mutant library, it is characterised in that: the method X1) or X2):
The method X1) include following X11) and X12):
X11 DNA fragmentation) is imported into target organisms, obtains genetically modified organism;The DNA fragmentation can be in the genetically modified organism
The required element of rite-directed mutagenesis target DNA is completed in middle expression;
X12 the genetically modified organism) is cultivated, biological mutant library is obtained;
The method X2) include following X21) and X22):
X21 DNA fragmentation) is imported into target organisms, obtains genetically modified organism;The DNA fragmentation can be in the genetically modified organism
The required element of rite-directed mutagenesis target DNA is completed in middle expression;
X22 the genetically modified organism) is cultivated, the individual of target DNA mutation is selected to obtain from the genetically modified organism
To biological mutant library, selection is containing the DNA fragmentation from the genetically modified organism and the target DNA do not mutate
Individual is bred, to expand the mutant library.
2. according to the method described in claim 1, it is characterized by: the biology is that mictic organism or asexual reproduction are raw
Object.
3. according to the method described in claim 1, the transgenosis is raw it is characterized by: the biology is mictic organism
Object can the specifically target DNA described in rite-directed mutagenesis in reproduction cell.
4. method according to claim 1 to 3, it is characterised in that: at least one in the element is thin by reproduction
The starting expression of born of the same parents' specific promoter.
5. according to the method described in claim 4, it is characterized by: the reproduction cell specific promoter is that egg cell specifically opens
Mover, pollen cell specific promoter or meiosis specific promoter.
6. any method in -5 according to claim 1, it is characterised in that: the element be CRISPR/Cas method or
Element needed for CRISPR/Cpf1 method.
7. according to the method described in claim 6, it is characterized by: the CRISPR/Cas method or CRISPR/Cpf1 method
Needed for element include a1) or a2):
A1) DNA restriction endonuclease and sgRNA;
A2) the DNA restriction endonuclease, crRNA and tracrRNA.
8. any method in -7 according to claim 1, it is characterised in that: the DNA fragmentation contains b1) or b2):
B1 the expression cassette of the DNA restriction endonuclease) can be expressed and the expression cassette of the sgRNA can be expressed;
B2 the expression cassette of the DNA restriction endonuclease) can be expressed, the expression cassette of the crRNA can be expressed and described in capable of expressing
The expression cassette of tracrRNA;
Further, the DNA fragmentation can also express the selection markers that can be used for screening transgenic biology.
9. -8 any method according to claim 1, it is characterised in that: the target DNA is and biotic stress, abiotic
Adverse circumstance, yield traits, quality trait or secondary metabolites correlation DNA.
10. in claim 1-9 any the method screening antibiont adverse circumstance, resisting abiotic adverse circumstance, high yield, good quality or
Application in high secondary metabolites mutant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018104006077 | 2018-04-28 | ||
CN201810400607 | 2018-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110408647A true CN110408647A (en) | 2019-11-05 |
Family
ID=68293466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910274109.7A Pending CN110408647A (en) | 2018-04-28 | 2019-04-08 | A kind of construction method of biology mutant library |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110408647A (en) |
WO (1) | WO2019205919A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117660525A (en) * | 2024-01-30 | 2024-03-08 | 三亚中国农业科学院国家南繁研究院 | Rice haploid induction method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105821073A (en) * | 2015-01-27 | 2016-08-03 | 中国科学院遗传与发育生物学研究所 | Method of site-directed modification for intact plant by means of gene transient expression |
CN105916987A (en) * | 2013-08-22 | 2016-08-31 | 纳幕尔杜邦公司 | Plant genome modification using guide RNA/Cas endonuclease systems and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450785A (en) * | 2014-12-08 | 2015-03-25 | 复旦大学 | Genome editing method using attachment carrier for encoding targeted endonuclease and kit |
CN106086062A (en) * | 2016-04-19 | 2016-11-09 | 上海市农业科学院 | A kind of tomato dna group that obtains pinpoints the method knocking out mutant |
-
2019
- 2019-04-08 CN CN201910274109.7A patent/CN110408647A/en active Pending
- 2019-04-08 WO PCT/CN2019/081654 patent/WO2019205919A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105916987A (en) * | 2013-08-22 | 2016-08-31 | 纳幕尔杜邦公司 | Plant genome modification using guide RNA/Cas endonuclease systems and methods of use |
CN105821073A (en) * | 2015-01-27 | 2016-08-03 | 中国科学院遗传与发育生物学研究所 | Method of site-directed modification for intact plant by means of gene transient expression |
Non-Patent Citations (1)
Title |
---|
陈易雨 等: "CRISPR/Cas9单碱基编辑技术创制抗除草剂拟南芥种质", 《中国科学: 生命科学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117660525A (en) * | 2024-01-30 | 2024-03-08 | 三亚中国农业科学院国家南繁研究院 | Rice haploid induction method |
CN117660525B (en) * | 2024-01-30 | 2024-04-26 | 三亚中国农业科学院国家南繁研究院 | Rice haploid induction method |
Also Published As
Publication number | Publication date |
---|---|
WO2019205919A1 (en) | 2019-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7250553B2 (en) | System for functional gene discovery in plants | |
US20240065193A1 (en) | Oilseed plants having reduced pod shatter | |
CN112725374A (en) | Method for creating plant haploid induction line and application thereof | |
US20230313179A1 (en) | Methods for improving traits in plants | |
BR112021009416A2 (en) | nucleic acid sequences for dbn8002 soybean plant detection and methods of detection thereof | |
CN109879944B (en) | EAR1 protein related to plant drought resistance and coding gene and application thereof | |
US20190017067A1 (en) | Glyphosate tolerant plants having modified 5-enolpyruvylshikimate-3-phosphate synthase gene regulation | |
CN110699374B (en) | Cultivation method of glyphosate-resistant rape | |
NL2015753B1 (en) | Non-transgenic haploid inducer lines in cucurbits. | |
CN112322633B (en) | Rice root-knot nematode resistance gene OsBetvI and application thereof | |
CN109971763A (en) | Florescence control gene C MP1 and relevant carrier and its application | |
CN110408647A (en) | A kind of construction method of biology mutant library | |
US11840693B2 (en) | Restorer plants | |
CN112980874B (en) | Application of GhCIPK6D1 gene in improving drought resistance of cotton | |
CN114656546A (en) | Parthenogenesis haploid inducing gene and application thereof | |
US11312967B2 (en) | Restorer plants | |
CN117305266B (en) | Gene OsBDG1 related to rice stress resistance and application of coded protein thereof | |
CN113322266B (en) | Application of rice OsRHD1-1 gene in rice male sterile line cultivation | |
CN110904120B (en) | Embryo development regulation gene DRR1, and encoded protein and application thereof | |
Thoris | YIELD IMPROVEMENT IN ORYZA SATIVA BY MANIPULATING THE PLA1/GE PATHWAY WITH CRISPR/CAS9 | |
WO2023135335A1 (en) | Modified tom2a gene involved in tobamovirus resistance | |
CN118126150A (en) | Application of GmSIG gene in regulation of soybean plant type | |
WO2017081009A1 (en) | Non-transgenic haploid inducer lines in cucurbits | |
JP2002253071A (en) | Plant body having disrupted gene encoding cell membrane proton-atpase and method for using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191105 |